卖什么
Targeting Cancer with Click Chemistry
商业模式拆解
买家：谁掌握预算？
Pharma and biotech business-development and oncology R&D teams seeking pre-targeting collaborations (site invites partners to contact bd@shasqi.com).
触发点：什么让他们现在购买？
Less than 1% of administered drugs reach the intended location in the body; ADC and radiopharma programs are limited by off-target toxicity and a narrow therapeutic window.
工作流：什么输入变成什么输出？
Pre-targeting in three steps: infuse a clickable binder that attaches to tumor antigens and clears elsewhere, infuse a clickable inactive payload (radioisotope or cancer drug), then the payload clicks with the binder at the tumor and is activated.
经济账：省了什么，怎么收费？
未核实Platform-and-pipeline drug developer: the pipeline page offers collaborations on antigen-targeted CAPAC combinations; revenue would come from partnerships and licensing and from advancing its own therapies (no terms stated).
渠道：怎么接触到客户？
Business-development led collaborations: the pipeline page asks interested parties to email bd@shasqi.com.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2015 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-13.